Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
18.08
-0.36 (-1.95%)
Mar 3, 2026, 4:00 PM EST - Market closed
Takeda Pharmaceutical Market Cap
Takeda Pharmaceutical has a market cap or net worth of $56.13 billion as of March 4, 2026. Its market cap has increased by 30.75% in one year.
Market Cap
56.13B
Enterprise Value
86.34B
1-Year Change
30.75%
Ranking
Category
Stock Price
$18.08
Market Cap Chart
Since January 5, 2010, Takeda Pharmaceutical's market cap has decreased from $71.21B to $56.13B, a decrease of -21.18%. That is a compound annual growth rate of -1.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 57.12B | 17.28% |
| Dec 31, 2025 | 48.70B | 15.61% |
| Dec 31, 2024 | 42.13B | -5.91% |
| Dec 29, 2023 | 44.78B | -7.43% |
| Dec 30, 2022 | 48.37B | 13.50% |
| Dec 31, 2021 | 42.62B | -24.84% |
| Dec 31, 2020 | 56.70B | -8.18% |
| Dec 31, 2019 | 61.76B | 134.31% |
| Dec 31, 2018 | 26.36B | -59.21% |
| Dec 30, 2016 | 64.61B | -22.54% |
| Dec 31, 2015 | 83.40B | 20.68% |
| Dec 31, 2014 | 69.11B | -9.90% |
| Dec 31, 2013 | 76.71B | 3.69% |
| Dec 31, 2012 | 73.97B | 0.68% |
| Dec 30, 2011 | 73.47B | -9.45% |
| Dec 31, 2010 | 81.14B | 13.94% |
| Jan 5, 2010 | 71.21B | - |
View and export this data all the way back to 2010. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zoetis | 55.34B |
| Haleon | 48.63B |
| Teva Pharmaceutical Industries | 39.43B |
| United Therapeutics | 22.08B |
| Viatris | 17.19B |
| Neurocrine Biosciences | 13.27B |
| Elanco Animal Health | 13.13B |
| Regencell Bioscience Holdings | 12.97B |